과제정보
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, & Future Planning (2020R1I1A3073338).
참고문헌
- Abdallah SM, Wong A : Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? Curr Oncol 25(Suppl 1) : S103-S114, 2018
- Baschnagel AM, Meyer KD, Chen PY, Krauss DJ, Olson RE, Pieper DR, et al. : Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife surgery. J Neurosurg 119 : 1139-1144, 2013 https://doi.org/10.3171/2013.7.JNS13431
- Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D : Performance status score: do patients and their oncologists agree? Br J Cancer 89 : 1022-1027, 2003 https://doi.org/10.1038/sj.bjc.6601231
- Broniscer A, Panetta JC, O'Shaughnessy M, Fraga C, Bai F, Krasin MJ, et al. : Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420. Clin Cancer Res 13 : 1511-1515, 2007 https://doi.org/10.1158/1078-0432.ccr-06-2372
- Chan BA, Hughes BG : Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 4 : 36-54, 2015 https://doi.org/10.3978/j.issn.2218-6751.2014.05.01
- Chin LS, Ma L, DiBiase S : Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94 : 899-904, 2001 https://doi.org/10.3171/jns.2001.94.6.0899
- Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L, et al. : Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients. Onco Targets Ther 6 : 1789-1803, 2013
- Frischer JM, Fraller A, Mallouhi A, Vogl UM, Baier F, Ertl A, et al. : Evaluation of dose-staged gamma knife radiosurgical treatment method for high-risk brain metastases. World Neurosurg 94 : 352-359, 2016 https://doi.org/10.1016/j.wneu.2016.07.038
- Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 : 745-751, 1997 https://doi.org/10.1016/S0360-3016(96)00619-0
- Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, et al. : Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74 : 1543-1548, 2009 https://doi.org/10.1016/j.ijrobp.2008.10.035
- Hochmair M : Medical treatment options for patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer suffering from brain metastases and/or leptomeningeal disease. Target Oncol 13 : 269-285, 2018 https://doi.org/10.1007/s11523-018-0566-1
- Jung EW, Choi J, Chao ST, Murphy ES, Suh JH : Chapter 8 - Principles and Tenets of Radiation Treatment in Glioblastoma in Brem S, Abdullah KG (eds) : Glioblastoma, ed 1. Amsterdam : Elsevier, 2016, pp105-132
- Kamiryo T, Lopes MB, Kassell NF, Steiner L, Lee KS : Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil. Neurosurgery 49 : 409-414; discussion 414-415, 2001 https://doi.org/10.1097/00006123-200108000-00026
- Kim KH, Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, et al. : The influence of histology on the response of brain metastases to gamma knife radiosurgery: a propensity score-matched study. Acta Neurochir (Wien) 160 : 2379-2386, 2018 https://doi.org/10.1007/s00701-018-3726-2
- Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, et al. : Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16 : e270-e278, 2015 https://doi.org/10.1016/S1470-2045(15)70057-4
- Mekhail T, Sombeck M, Sollaccio R : Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. Curr Oncol Rep 13 : 255-258, 2011 https://doi.org/10.1007/s11912-011-0180-1
- Miyatake S, Nonoguchi N, Furuse M, Yoritsune E, Miyata T, Kawabata S, et al. : Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain. Neurol Med Chir (Tokyo) 55 : 50-59, 2015 https://doi.org/10.2176/nmc.ra.2014-0188
- Mohammadi AM, Schroeder JL, Angelov L, Chao ST, Murphy ES, Yu JS, et al. : Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases. J Neurosurg 126 : 735-743, 2017 https://doi.org/10.3171/2016.3.JNS153014
- Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, et al. : The distribution of vascular endothelial growth factorproducing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105 : 423-431, 2011 https://doi.org/10.1007/s11060-011-0610-9
- Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, et al. : Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med 377 : 829-838, 2017 https://doi.org/10.1056/NEJMoa1704795
- Reungwetwattana T, Nakagawa K, Cho BC, Cobo M, Cho EK, Bertolini A, et al. : CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer. J Clin Oncol 36 : 33, 3290-3297, 2018 https://doi.org/10.1200/jco.2018.78.3118
- Schimmel WCM, Verhaak E, Hanssens PEJ, Gehring K, Sitskoorn MM : A randomised trial to compare cognitive outcome after gamma knife radiosurgery versus whole brain radiation therapy in patients with multiple brain metastases: research protocol CAR-study B. BMC Cancer 18 : 218, 2018 https://doi.org/10.1186/s12885-018-4106-2
- Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. : Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47 : 291-298, 2000 https://doi.org/10.1016/S0360-3016(99)00507-6
- Sun YW, Xu J, Zhou J, Liu WJ : Targeted drugs for systemic therapy of lung cancer with brain metastases. Oncotarget 9 : 5459-5472, 2018 https://doi.org/10.18632/oncotarget.23616
- Trnovec T, Kallay Z, Bezek S : Effects of ionizing radiation on the blood brain barrier permeability to pharmacologically active substances. Int J Radiat Oncol Biol Phys 19 : 1581-1587, 1990 https://doi.org/10.1016/0360-3016(90)90376-U
- van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY : Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). Oncol Rep 9 : 683-688, 2002
- Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH : Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104 : 907-912, 2006 https://doi.org/10.3171/jns.2006.104.6.907
- Wrona A, Dziadziuszko R, Jassem J : Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors. Cancer Treat Rev 71 : 59-67, 2018 https://doi.org/10.1016/j.ctrv.2018.10.011
- Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. : Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15 : 387-395, 2014 https://doi.org/10.1016/S1470-2045(14)70061-0
- Yomo S, Hayashi M : A minimally invasive treatment option for large metastatic brain tumors: long-term results of two-session Gamma knife stereotactic radiosurgery. Radiat Oncol 9 : 132, 2014 https://doi.org/10.1186/1748-717X-9-132
- Yu JB, Schulder M, Knisely J : Radiosurgical dose selection for brain metastasis. Prog Neurol Surg 25 : 139-147, 2012 https://doi.org/10.1159/000331187
- Zhao J, Chen M, Zhong W, Zhang L, Li L, Xiao Y, et al. : Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer 14 : 188-193, 2013 https://doi.org/10.1016/j.cllc.2012.06.004
- Zhuang H, Shi S, Yuan Z, Chang JY : Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues. Mol Cancer 18 : 21, 2019 https://doi.org/10.1186/s12943-019-0950-1